SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-016244
Filing Date
2023-05-11
Accepted
2023-05-11 06:05:29
Documents
14
Period of Report
2023-05-09
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 47275
2 ex3-1.htm EX-3.1 21189
3 ex99-1.htm EX-99.1 11985
  Complete submission text file 0001493152-23-016244.txt   264218

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE ladx-20230509.xsd EX-101.SCH 3230
5 XBRL LABEL FILE ladx-20230509_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE ladx-20230509_pre.xml EX-101.PRE 22361
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3686
Mailing Address 11726 SAN VICENTE BOULEVARD SUITE 650 LOS ANGELES CA 90049
Business Address 11726 SAN VICENTE BOULEVARD SUITE 650 LOS ANGELES CA 90049 310-826-5648
LadRx Corp (Filer) CIK: 0000799698 (see all company filings)

IRS No.: 581642750 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-15327 | Film No.: 23908649
SIC: 2836 Biological Products, (No Diagnostic Substances)